Researchers at Texas A&M University model extreme conditions using 3D bioprinting, revealing insights that could make flight ...
3D bio-printed liver model and high-content imaging for evaluating the toxicity effects of compounds
The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...
SCHLIEREN, ZüRICH, SWITZERLAND, November 11, 2025 /EINPresswire.com/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems ...
Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...
In associate professor Mauro Tambasco's lab, researchers at all levels work together to develop innovative approaches to ...
Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...
Researchers recently developed a bone marrow model to study how the body generates cells. Interestingly, this model is the ...
DUBLIN--(BUSINESS WIRE)--Inventia Life Science, a leading advanced cell model company, launched the Inventia Third Dimension Grant today. This grant will allow researchers studying fundamental biology ...
(MENAFN- EIN Presswire) EINPresswire/ -- InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire the DOPPL SA, a ...
InSphero acquires DOPPL SA and Sun Bioscience’s Gri3D® platform, expanding its unified 3D spheroid–organoid ecosystem for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback